Cirsiliol alleviates experimental inflammatory bowel disease via restoration of intestinal barrier integrity and inhibition of NF-κB and MAPK pathways

Related articles

1. Licorice Flavonoid Extract Ameliorates Intestine Damage in Ulcerative Colitis via MAPK/NF-κB Signaling Modulation and Gut Microbiome Remodeling

   This article has 8 authors:

   1. Xiaoai Zhu
   2. Binsong Han
   3. Anqi Hu
   4. Jiacen Bi
   5. Wenxue Wang
   6. Yuhui Ye
   7. Feng Xue
   8. Cunzheng Zhang

2. A20 inhibites intestinal mucosal permeability of IBS-D rats by regulating STAT3 signaling pathway

   This article has 8 authors:

   1. Jiaman Lin
   2. Yongquan Huang
   3. Zefang Yang
   4. Xiling Yang
   5. Jiahe Zhang
   6. Danting Shen
   7. Caiyan Wang
   8. Qiuke Hou

3. Inhibition of the T2R/α-Defensin Pathway Mediates Nauclea officinalis-Induced Intestinal Barrier Dysfunction and Microbiota Alterations

   This article has 11 authors:

   1. Xiaoman Li
   2. Yao Yi
   3. Tegele Si
   4. Lianqian Wang
   5. Zhiyong Hu
   6. Jiayue Xiong
   7. Xuemei Bao
   8. Jun Jun
   9. Sachurula Bao
   10. Xiaoping Ji
   11. Minghai Fu